Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals

Leukemia. 2008 Sep;22(9):1773-8. doi: 10.1038/leu.2008.41. Epub 2008 Mar 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Cell Cycle / genetics
  • Core Binding Factor Alpha 3 Subunit / genetics*
  • Diagnosis, Differential
  • Gene Expression Profiling*
  • Genes, Neoplasm*
  • Humans
  • Janus Kinase 2 / genetics
  • Myeloproliferative Disorders / classification
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / genetics
  • Transforming Growth Factor beta / genetics
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Biomarkers, Tumor
  • Core Binding Factor Alpha 3 Subunit
  • Runx3 protein, human
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • JAK2 protein, human
  • Janus Kinase 2